Patents expiring in 2028

US 7459458

Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

Neurocrine Biosciences, Inc. · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459601

Human α synuclein expressing transgenic mice

The Regents of the University of California · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459462

Fredericamycin derivatives

Biofrontera Discovery GmbH · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459536

HGF-SF monoclonal antibody combinations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459453

Pyridazin-3(2H)-one derivatives as PDE4 inhibitors

Laboratories Almirall, S.A. · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459439

Granulysin peptides and methods of use thereof

The Regents of the University of California · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459156

Antibodies that mimic actions of neurotrophins

The Regents of the University of California · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462612

Pyridine inhibitors of ERK2 and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462743

Polymorphs of memantine hydrochloride

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462737

Pregabalin free of isobutylglutaric acid and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462635

Thiazole and oxazole VDAC regulator

Takeda Pharmaceutical Company Limited · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462609

Narcistatin prodrugs

THE ARIZONA BOARD OF REGENTS · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462625

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462356

Chimeric papillomavirus-like particles

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462691

Mouse prostate stem cell antigen and uses thereof

The Regents of the University of California · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462603

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery

The Regents of the University of California · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462345

Radionuclide labeling of vitamin B12 and coenzymes thereof

Regents of the University of Minnesota · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7462628

Preventives/remedies for urinary disturbance

Takeda Pharmaceutical Company Limited · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465748

Amide derivative

Rational Drug Design Laboratories · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465716

Targeted drug delivery with a hyaluronan ligand

The Regents of the University of California · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465715

Method for treatment of multiple sclerosis

CAN-FITE BIOPHARMA LTD. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465449

Anti-αvβ6 antibodies

The Regents of the University of California · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465466

Compositions and methods for prostate and kidney health and disorders, an herbal preparation

Integrated Chinese Medicine Holdings Ltd. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465784

Antimicrobial peptides and methods of identifying the same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465794

Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465815

Cannabinoid receptor modulator

Takeda Pharmaceutical Company Limited · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465738

Compounds useful as promoters of SMN2

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465831

Levalbuterol hydrochloride Polymorph A

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465825

Phenyl substituted carboxylic acids

The Institute for Pharmaceutical Discovery, LLC · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468352

Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468379

Inhibition of osteolytic lesions by SRC kinase inhibitors

The Board of Regents of the University of Texas System · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468426

Oncoprotein protein kinase antibody kit

The Regents of the University of California · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468420

Process for purifying glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468432

Cobalamin conjugates useful as antitumor agents

Regents of the University of Minnesota · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468444

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468435

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468419

Cyclosporin derivatives for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468394

Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation

Amphastar Pharmaceuticals, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470431

Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

The Regents of the University of Colorado · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470420

Optical determination of glucose utilizing boronic acid adducts

The Regents of the University of California · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470430

Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470659

Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)

The Regents of the University of California · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470775

Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470660

Treatment for dark adaptation

The Regents of the University of California · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470790

Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

Northwestern University · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470776

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470700

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470506

Fitness assay and associated methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)